Showing results (141-150 of 173) with videos related to

Sort By:
Pageof 18
Progress in Neuro-Psychopharmacology & Biological Psychiatry|April 6, 2025
Exploratory study on plasma Acylglycerol and Acylethanolamide dysregulation in substance use and attention-deficit/hyperactivity disorder: Implications for novel biomarkers in dual diagnosisMaría Flores-López, Jesús Herrera-Imbroda, Nerea Requena-Ocaña, et al.
The European Journal of Neuroscience|October 5, 2012
Diet-dependent modulation of hippocampal expression of endocannabinoid signaling-related proteins in cannabinoid antagonist-treated obese ratsPatricia Rivera, María Jesús Luque-Rojas, Antoni Pastor, et al.
American Journal of Physiology. Endocrinology and Metabolism|February 3, 2012
Adiponectin promoter activator NP-1 reduces body weight and hepatic steatosis in high-fat diet-fed animalsAntonia Serrano, Francisco J Pavón, Juan Suarez, et al.
British Journal of Pharmacology|September 29, 2011
Anti-obesity efficacy of LH-21, a cannabinoid CB(1) receptor antagonist with poor brain penetration, in diet-induced obese ratsMónica Alonso, Antonia Serrano, Margarita Vida, et al.
Plos One|November 7, 2017
Decreased plasma concentrations of BDNF and IGF-1 in abstinent patients with alcohol use disordersNuria García-Marchena, Daniel Silva-Peña, Ana Isabel Martín-Velasco, et al.
Addiction Biology|June 4, 2015
Role of the satiety factor oleoylethanolamide in alcoholismAinhoa Bilbao, Antonia Serrano, Andrea Cippitelli, et al.
Pageof 18